Damora Therapeutics amended a Schedule 13G/A to disclose reporting by Jain Global LLC, Jain Holdings LLC, and Robert Jain concerning Common Stock (CUSIP 36322Q206). The filing states the Reporting Persons hold 0.0% of the class and reports $0.00001 par value per share; ownership rows on the cover show zeros for voting and dispositive powers.
The amendment is signed by an authorized signatory and notes a previously filed power of attorney; it is an ownership disclosure for holders of 5% or less.
Positive
None.
Negative
None.
Insights
Disclosure confirms passive/minimal holding by reporting entities.
The filing lists Jain Global LLC, Jain Holdings LLC, and Robert Jain as joint filers regarding Shares of Damora Therapeutics (CUSIP 36322Q206). The cover rows show 0.0% ownership and zero voting/dispositive power entries, indicating holdings at or below the 5% reporting threshold.
Cash‑flow treatment and specific share counts are not shown in the excerpt; subsequent amendments would show any material changes if reporting persons cross thresholds.
Amendment documents signature authority and procedural linkage to prior POA.
The amendment incorporates a previously filed power of attorney and identifies Noah Goldberg signing as authorized signatory and attorney‑in‑fact. This clarifies execution authority for the Schedule 13G/A filings.
Filing mechanics and the Ownership of 5 Percent or Less of a Class classification are explicit; materiality to shareholders is routine and procedural.
Key Figures
Beneficial ownership percent:0.0%CUSIP:36322Q206Par value:$0.00001 per share+3 more
Par value$0.00001 per shareCommon Stock par value stated on cover
Cover page voting powers0.00 (sole/shared)Rows 5–8 on cover page show zeros
Signature date05/15/2026Signatures by authorized signatory
Report reference date03/31/2026Date appearing near header
Key Terms
Schedule 13G/A, beneficially owned, dispositive power, power of attorney
4 terms
Schedule 13G/Aregulatory
"Amendment No. 1; joint filing by Jain Global LLC and others"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially ownedregulatory
"Item 4. (a) Amount beneficially owned: The information required by Item 4(a)"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
dispositive powerregulatory
"Row 7 | Sole Dispositive Power 0.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
power of attorneylegal
"Noah Goldberg is signing on behalf of Robert Jain as attorney-in-fact"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Damora Therapeutics, Inc.
(Name of Issuer)
Common Stock, $0.00001 par value per share
(Title of Class of Securities)
36322Q206
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
36322Q206
1
Names of Reporting Persons
Jain Global LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
IA, OO
SCHEDULE 13G
CUSIP Number(s):
36322Q206
1
Names of Reporting Persons
Jain Holdings LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
HC, OO
SCHEDULE 13G
CUSIP Number(s):
36322Q206
1
Names of Reporting Persons
Robert Jain
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Damora Therapeutics, Inc.
(b)
Address of issuer's principal executive offices:
221 Crescent Street, Building 23, Suite 105, Waltham, Massachusetts 02453
Item 2.
(a)
Name of person filing:
This Schedule 13G is being jointly filed by Jain Global LLC ("Jain Global"), a registered investment adviser, Jain Holdings LLC ("Jain Holdings"), and Mr. Robert Jain (collectively with Jain Global and Jain Holdings, the "Reporting Persons") with respect to the common stock, $0.00001 par value per share ("Shares"), of Damora Therapeutics, Inc. (the "Company") owned by Jain Global Master Fund Ltd (the "Fund").
Jain Global is the investment manager for the Fund. Jain Holdings is the sole member of Jain Global. Mr. Jain is the Chief Executive Officer and Chief Investment Officer of Jain Global, and owns a controlling interest in Jain Holdings.
This Schedule 13G shall not be construed as an admission by the Reporting Persons that they are the beneficial owners of any of the Shares covered by this Schedule 13G.
(b)
Address or principal business office or, if none, residence:
The address of each of the Reporting Persons is 9 West 57th Street, 39th Floor, New York, New York, 10019.
(c)
Citizenship:
Each of Jain Global and Jain Holdings is organized as a limited liability company under the laws of the State of Delaware. Mr. Jain is a U.S. citizen.
(d)
Title of class of securities:
Common Stock, $0.00001 par value per share
(e)
CUSIP No.:
36322Q206
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(b)
Percent of class:
0.0%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(ii) Shared power to vote or to direct the vote:
The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iii) Sole power to dispose or to direct the disposition of:
The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iv) Shared power to dispose or to direct the disposition of:
The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Jain Global LLC
Signature:
/s/ Noah Goldberg
Name/Title:
NOAH GOLDBERG, AUTHORIZED SIGNATORY
Date:
05/15/2026
Jain Holdings LLC
Signature:
/s/ Noah Goldberg
Name/Title:
NOAH GOLDBERG, AUTHORIZED SIGNATORY
Date:
05/15/2026
Robert Jain
Signature:
/s/ Noah Goldberg
Name/Title:
NOAH GOLDBERG, ATTORNEY-IN-FACT*
Date:
05/15/2026
Comments accompanying signature: *Noah Goldberg is signing on behalf of Robert Jain as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission and hereby incorporated by reference herein. The power of attorney was filed as an attachment to a filing by Jain Global LLC on Schedule 13G for the Company (then Galecto, Inc.) on February 17, 2026.
What does Damora Therapeutics' Schedule 13G/A with symbol DMRA disclose?
It discloses that Jain Global LLC, Jain Holdings LLC, and Robert Jain jointly filed a Schedule 13G/A. The filing shows 0.0% ownership of Damora Therapeutics common stock (CUSIP 36322Q206) and zero voting/dispositive powers as listed on the cover.
Who are the Reporting Persons named in the DMRA Schedule 13G/A?
The Reporting Persons are Jain Global LLC, Jain Holdings LLC, and Robert Jain. The filing states Jain Global is investment manager for a Fund and Jain Holdings is its sole member; Mr. Jain is CEO and CIO of Jain Global.
Does the Schedule 13G/A show any beneficial ownership percentage for DMRA?
Yes; the filing reports a beneficial ownership percentage of 0.0% for the Reporting Persons. Row entries on the cover indicate 0.00 for sole and shared voting and dispositive powers.
Who signed the Schedule 13G/A amendment for DMRA and under what authority?
The amendment is signed by Noah Goldberg as authorized signatory and as attorney‑in‑fact for Robert Jain. It references a previously filed power of attorney incorporated by reference in the filing.
Does this filing indicate a change that requires further SEC disclosure for DMRA?
The filing classifies the position as "Ownership of 5 Percent or Less of a Class." It does not by itself trigger larger disclosures; any future change above 5% would require updated filings under applicable rules.
